Rosetta Genomics Ltd. Operating Cash Flow
Rosetta Genomics Ltd. reported Operating Cash Flow of -$7.05 million for the 6-month period ending 2017-06-30, per its 6-K filed 2017-10-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2017-10-10
| Period end | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|
| 2017-06-30 | -$7.05M 6-K · filed 2017-10-10 | ||
| 2016-12-31 | $10.37M 6-K · filed 2017-10-10 | -$10.37M 20-F · filed 2017-03-30 | |
| 2016-06-30 | -$4.96M 6-K · filed 2017-10-10 | ||
| 2015-12-31 | -$16.93M 20-F · filed 2017-03-30 | ||
| 2014-12-31 | -$13.60M 20-F · filed 2017-03-30 | ||
| 2014-06-30 | -$7.56M 6-K · filed 2014-09-17 | ||
| 2013-12-31 | -$10.61M 6-K · filed 2016-12-08 | ||
| 2013-06-30 | -$4.59M 6-K · filed 2014-09-17 | ||
| 2012-12-31 | -$8.64M 20-F · filed 2015-03-16 | ||
| 2012-06-30 | -$4.90M 6-K · filed 2013-09-09 | ||
| 2011-12-31 | -$11.26M 20-F · filed 2014-03-31 | ||
| 2011-06-30 | -$5.83M 6-K · filed 2012-09-28 | ||
| 2010-12-31 | -$13.72M 20-F · filed 2013-03-22 | ||
| 2009-12-31 | -$11.77M 6-K · filed 2012-12-07 |